
11. septembre 2024Transactions & cas
Deal Ticker: Kellerhals Carrard advises Broadview Ventures and Panakes Partners in the EUR 44 million Series B Financing Round of CorFlow Therapeutics
We are thrilled to have advised Broadview Ventures Inc and Panakes Partners in leading the EUR 44 million Series B financing round of CorFlow Therapeutics! This round also includes participation from Merieux Equity Partners, Laerdal Million Lives Fund, Wellington Partners, M&L INVESTMENTS, L.C., Unorthodox Ventures, Kofa Healthcare and Monte Carlo Capital, with continued support from 415 Capital, CorFlow's initial VC investor and largest shareholder. Contacts![]() Dr. Karim MaizarTél. +41 58 200 39 00 karim.maizar@kellerhals-carrard.ch ![]() Umberto MilanoTél. +41 58 200 39 00 Fax +41 58 200 39 11 umberto.milano@kellerhals-carrard.ch ![]() Céline SchmidTél. +41 58 200 39 00 Fax +41 58 200 39 11 celine.schmid@kellerhals-carrard.ch ![]() Dr. Vera ValloneTél. +41 58 200 39 00 Fax +41 58 200 39 11 vera.vallone@kellerhals-carrard.ch ![]() Melissa WissTél. +41 58 200 39 00 Fax +41 58 200 39 11 melissa.wiss@kellerhals-carrard.ch |